NCT00916643View on ClinicalTrials.gov

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Familial Hypercholesterolemia
Interventions
DEVICE

HELP Secura (apheresis treatment)

Process is described in Arm (above).

All Listed Sponsors
lead

B. Braun Medical Inc.

INDUSTRY

NCT00916643 - Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy | Biotech Hunter | Biotech Hunter